TY - JOUR T1 - The Prevalence of RT-PCR Positivity of SARS-CoV-2 on 10,000 Patients from Three Cities Located on the Eastern of Turkey JF - medRxiv DO - 10.1101/2020.06.25.20138131 SP - 2020.06.25.20138131 AU - Karamese Murat AU - Ozgur Didem AU - Tarhan Ceyda AU - Dik Altintas Susamber AU - Caliskan Okan AU - Tuna Aysegul AU - Kazci Saliha AU - Karadavut Mursel AU - Gumus Abdullah AU - Apaydin Gozde AU - Mumcu Necati AU - Coruh Onur AU - Tutuncu Emin Ediz Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/26/2020.06.25.20138131.abstract N2 - COVID-19, is caused by SARS-CoV-2, has been started on December/2019 in Wuhan/China and spread all over the world. We analyzed RT-PCR results of 10,000 cases from April-2 to May-30, 2020 in three neighbor cities located on the Eastern of Turkey. The final study population was 7853 cases after excluded screening tests. RT-PCR were performed to detect the SARS-CoV-2-specific RdRp (RNA-dependent-RNA-polymerase) gene fragment. The number of total positive samples out of 7853 were 487; however, the number of non-repeating positive patient was 373 (4.8%). The cough and fever were the most common symptoms in positive cases. The epidemiologic studies should be performed about the prevalence of SARS-CoV-2 infection to better understand the effect of the virus all over the world.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by both the Republic of Turkey Ministry of Health COVID19 Scientific Research Evaluation Commission (Approval date: 02.05.2020; number: 2020-05-03T18_02_30) and the Local Ethics Committee of Kafkas University Faculty of Medicine (Approval date: 06.05.2020 number: 80576354-050-99/129).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesthe availability of all data referred to in the manuscript ER -